MAB'Solut Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

MAB'Solut General Information

Description

Developer of monoclonal antibodies. The company is engaged in the research and development of immune antibodies for the treatment of ophthalmic diseases, cancers, autoimmune and inflammatory diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
MABSolys
Primary Office
  • Génopole Campus 1
  • 5 rue Henri Desbruères
  • 91030 Evry Cedex
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MAB'Solut Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MAB'Solut‘s full profile, request access.

Request a free trial

MAB'Solut Executive Team (2)

Name Title Board Seat Contact Info
Thierry Guyon Ph.D Head, Laboratories
Rémi Borye Manager, Sales & Marketing
To view MAB'Solut’s complete executive team members history, request access »

MAB'Solut Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MAB'Solut‘s full profile, request access.

Request a free trial